Healthcare - Biotechnology - NASDAQ - US
$ 8.18
-4.77 %
$ 2.49 B
Market Cap
-5.53
P/E
INCOME STATEMENT
1.19 M
REVENUE
-461 M
OPERATING INCOME
-444 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Iovance Biotherapeutics, Inc.
| Revenue | 1.19 M |
| Cost Of Revenue | 10.8 M |
| Gross Profit | -9.57 M |
| Operating Expenses | 451 M |
| Operating Income | -461 M |
| Other Expenses | -16.5 M |
| Net Income | -444 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||
| Revenue | 1.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||||||||||
| Cost Of Revenue | 10.8 | 21.1 | 14.0 | 8.7 | 8.1 | 1.0 | 1.0 | 1.0 | 1.0 | 9.3 | 4.7 | 6.5 | 19.3 | 0 | 0 | 0 |
| Gross Profit | (9.6) | (21.1) | (14.0) | (8.7) | (8.1) | (1.0) | (1.0) | (1.0) | (1.0) | (9.3) | (4.7) | (6.5) | (19.3) | 0 | 0 | 0 |
| OPERATING INCOME | ||||||||||||||||
| Operating Expenses | 451.0 | 398.9 | 342.7 | 261.9 | 206.9 | 128.3 | 92.9 | 53.6 | 27.9 | 12.0 | 22.6 | 8.1 | 21.1 | 0.8 | 15.8 K | 57.1 K |
| Selling, General and Administrative Expenses | 106.9 | 104.1 | 83.7 | 60.2 | 40.8 | 28.4 | 21.3 | 25.6 | 12.4 | 9.3 | 4.7 | 6.5 | 19.3 | 0 | 14.4 K | 25.6 K |
| Research and Development Expenses | 344.1 | 294.8 | 259.0 | 201.7 | 166.0 | 99.8 | 71.6 | 28.0 | 15.5 | 2.7 | 1.3 | 1.7 | 1.8 | 0 | 0 | 0 |
| Operating Income | (460.6) | (398.9) | (342.7) | (261.9) | (206.9) | (128.3) | (92.9) | (53.6) | (27.9) | (12.0) | (22.6) | (8.1) | (21.2) | (0.8) | 15.8 K | 57.1 K |
| PRE-TAX INCOME | ||||||||||||||||
| Interest Income Expense | 0 | 3.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 5.66 K | 0.4 | 2.4 | 0.2 | 0 | 0 | 0 |
| Total Other Income | 13.0 | 3.0 | 0.5 | 2.4 | 9.3 | 4.7 | 0.8 | 0.7 | 0.2 | 5.66 K | (2.7) | 4.8 | (4.5) | (0.8) | 0 | 0 |
| Pre-Tax Income | (447.5) | (395.9) | (342.3) | (259.6) | (197.6) | (123.6) | (92.1) | (52.9) | (27.7) | (12.0) | (25.4) | (3.3) | (25.7) | (1.6) | 15.8 K | 57.1 K |
| NET INCOME | ||||||||||||||||
| Tax Provision | (3.5) | (6.0) | (14.4) | (2.4) | (10.5) | 4.7 | (1.0) | (1.0) | (1.0) | 0 | 0.4 | 2.4 | 4.6 | 0.8 | 0 | 0 |
| Net Income | (444.0) | (389.9) | (327.8) | (257.2) | (187.1) | (123.6) | (92.1) | (52.9) | (27.7) | (12.0) | (25.4) | (3.3) | (25.7) | (1.6) | 15.8 K | 57.1 K |
| EPS | 1.89 | 2.45 | 2.14 | 1.86 | 1.5 | 1.27 | 1.41 | 0.96 | 0.62 | 0.48 | 2.6 | 4.14 | 33.8 | 2.46 | 0.0414 | 0.0471 |